$19 B

ABMD Mkt cap, 22-Jun-2018

$593.7 M

ABIOMED Revenue FY, 2018
ABIOMED Gross profit (FY, 2018)495.2 M
ABIOMED Gross profit margin (FY, 2018), %83.4%
ABIOMED Net income (FY, 2018)112.2 M
ABIOMED EBIT (FY, 2018)157.1 M
ABIOMED Cash, 31-Mar-201843 M

ABIOMED Financials

ABIOMED Income Statement

Annual

USDFY, 2014FY, 2015Y, 2016FY, 2017FY, 2018

Revenue

183.6 m230.3 m329.5 m445.3 m593.7 m

Revenue growth, %

25%43%35%

Cost of goods sold

98.6 m

Gross profit

495.2 m

Gross profit Margin, %

83%

R&D expense

66.4 m75.3 m

General and administrative expense

218.2 m262.7 m

Operating expense total

284.5 m436.6 m

EBIT

8.4 m28.7 m65.1 m90.1 m157.1 m

EBIT margin, %

5%12%20%20%26%

Pre tax profit

8.5 m28.8 m65.8 m91.3 m160.4 m

Income tax expense

1.2 m(84.9 m)27.7 m39.2 m48.3 m

Net Income

7.4 m113.7 m38.1 m52.1 m112.2 m

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

44.3 m46.2 m48.8 m51.9 m62 m73.4 m76.4 m85.8 m103 m103 m114.7 m132.5 m132.8 m

R&D expense

7.7 m7.8 m9.1 m8.7 m8.4 m10.2 m11.6 m13.8 m15.7 m18.1 m16.3 m16.9 m19.4 m

General and administrative expense

26.2 m24.4 m31.6 m29.5 m30.1 m37.3 m39.8 m41.9 m51 m53.1 m53.9 m60.6 m60.1 m

Operating expense total

42.9 m41.6 m50.3 m47.8 m48.3 m58.4 m63.5 m68.4 m81.8 m88.4 m89.3 m99.4 m101.1 m

EBIT

1.4 m4.6 m(1.5 m)4.2 m13.7 m15 m12.8 m17.4 m21.2 m14.5 m25.4 m33.1 m31.7 m

EBIT margin, %

3%10%(3%)8%22%20%17%20%21%14%22%25%24%

Pre tax profit

1.4 m4.7 m4.2 m13.7 m15.1 m13 m17.5 m21.4 m14.7 m25.8 m33.8 m32.5 m

Income tax expense

370 k258 k226 k336 k1 m6.3 m5.2 m6.9 m8.5 m5.9 m10.4 m(3.6 m)8 m

Net Income

1.1 m4.4 m(1.7 m)3.8 m12.7 m8.9 m7.7 m10.6 m12.9 m8.9 m15.4 m37.4 m24.5 m

ABIOMED Balance Sheet

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

20.9 m22.4 m48.2 m39 m43 m

Accounts Receivable

24.4 m31.8 m42.8 m54.1 m70 m

Inventories

13.9 m16.8 m26.7 m34.9 m50.2 m

Current Assets

118 m220.1 m288.4 m327 m494.3 m

PP&E

6.9 m9.1 m23.2 m87.8 m117.2 m

Goodwill

38 m31.5 m33 m31 m35.8 m

Total Assets

205.4 m338.4 m423.9 m550.4 m786.4 m

Accounts Payable

7.7 m10.4 m9.4 m20.6 m23.6 m

Short-term debt

Current Liabilities

30.4 m39.3 m46.5 m69.6 m84.7 m

Long-term debt

Total Liabilities

98.3 m96.9 m

Additional Paid-in Capital

436.1 m465 m508.6 m566 m619.9 m

Retained Earnings

(250.9 m)(137.2 m)(99.1 m)(47 m)140.5 m

Total Equity

168.4 m291.6 m368.8 m452.1 m689.5 m

Financial Leverage

1.2 x1.2 x1.1 x1.2 x1.1 x

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

10.1 m22.6 m34.7 m17.5 m19.5 m40.4 m54.4 m53.2 m38.3 m54.7 m61.1 m44 m44.5 m

Accounts Receivable

21.1 m23 m22.8 m23.1 m28.4 m34.4 m37.1 m36.8 m41.3 m46.6 m50.2 m53.6 m57.3 m

Inventories

15.6 m14.8 m13.9 m13.4 m15.4 m21.2 m23 m25.5 m29.1 m31.5 m32.1 m36.9 m40.6 m

Current Assets

110.6 m119.7 m127.2 m135.3 m160.6 m244.1 m265.4 m281.7 m300.3 m319.9 m333.4 m350.9 m370.2 m

PP&E

6.4 m7 m6.7 m7.4 m7.6 m10.2 m11.4 m15 m26 m50.2 m60.9 m92.8 m97.7 m

Goodwill

37.3 m38 m37.7 m36.9 m35.3 m32.2 m32.7 m31.7 m32.3 m32.6 m30.6 m33.2 m34.3 m

Total Assets

181 m193.4 m206.2 m215.5 m240.8 m352 m373.4 m391.6 m429.3 m474.9 m501 m652.2 m694.7 m

Accounts Payable

6.2 m6.1 m6.8 m7.6 m8.2 m8.6 m8.8 m8.8 m8.4 m14.1 m14.6 m12.8 m16.7 m

Current Liabilities

24 m26.4 m29 m27.1 m31.4 m36.3 m34.5 m37.7 m43.2 m51.9 m58.9 m59 m63.4 m

Total Liabilities

30.3 m32.9 m35.8 m40 m45.1 m44 m42.3 m46.1 m52 m76.5 m83.6 m85.2 m89.8 m

Additional Paid-in Capital

427.2 m431.8 m441.3 m447.4 m457.9 m474.5 m489.5 m496 m520.8 m536.9 m546.8 m580 m592.1 m

Retained Earnings

(258.9 m)(254.5 m)(252.6 m)(248.8 m)(236.1 m)(128.4 m)(120.6 m)(110.1 m)(86.2 m)(77.3 m)(61.9 m)65.7 m90.2 m

Total Equity

150.7 m160.5 m170.4 m175.5 m195.7 m308.1 m331.1 m345.5 m377.3 m398.4 m417.4 m567 m604.9 m

Financial Leverage

1.2 x1.2 x1.2 x1.2 x1.2 x1.1 x1.1 x1.1 x1.1 x1.2 x1.2 x1.2 x1.1 x

ABIOMED Cash Flow

Annual

USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

7.4 m113.7 m38.1 m52.1 m112.2 m

Depreciation and Amortization

2.8 m3.3 m6.2 m11 m

Accounts Receivable

(1.3 m)(8 m)(11 m)(11.6 m)(15.3 m)

Inventories

(622 k)(7 m)(11 m)(12.3 m)(15.7 m)

Accounts Payable

(54 k)3.4 m(2.6 m)7.6 m4.4 m

Cash From Operating Activities

23.5 m43.3 m76.8 m115.1 m192.5 m

Purchases of PP&E

(2.8 m)(5.2 m)(15.6 m)(50.4 m)(55.9 m)

Cash From Investing Activities

(22.3 m)(49.9 m)(57.7 m)(126.3 m)(180.8 m)

Cash From Financing Activities

9.6 m9.5 m7.2 m3.9 m(9.1 m)

Income Taxes Paid

1.3 m1.2 m848 k1.4 m4.6 m

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(664 k)3.7 m(1.7 m)3.8 m12.7 m8.9 m7.7 m10.6 m12.9 m8.9 m15.4 m

Depreciation and Amortization

1.3 m1.9 m

Accounts Receivable

1.9 m123 k22.8 m23.1 m28.4 m34.4 m37.1 m36.8 m41.3 m46.6 m50.2 m

Inventories

(876 k)(69 k)13.9 m13.4 m15.4 m21.2 m23 m25.5 m29.1 m31.5 m32.1 m

Accounts Payable

(1.5 m)(1.7 m)6.8 m7.6 m8.2 m8.6 m8.8 m8.8 m8.4 m14.1 m14.6 m

Cash From Operating Activities

5.1 m13.6 m

Purchases of PP&E

(1.2 m)(2.3 m)

Cash From Investing Activities

(10.1 m)(9.1 m)

Cash From Financing Activities

5.2 m8.1 m

Income Taxes Paid

1.1 m

ABIOMED Ratios

USDY, 2018

Revenue/Employee

653.9 k

Financial Leverage

1.1 x
Report incorrect company information